SOX10 has previously been identified as a higher‐specificity biomarker in recent melanoma literature (Szumera‐Ciećkiewicz et al. 2020; Willis et al. 2015) and was therefore selected as the melanoma‐specific CTC identifier in this study. Here, SOX10 is linked to melanoma.